UniProt ID | BATF_HUMAN | |
---|---|---|
UniProt AC | Q16520 | |
Protein Name | Basic leucine zipper transcriptional factor ATF-like | |
Gene Name | BATF | |
Organism | Homo sapiens (Human). | |
Sequence Length | 125 | |
Subcellular Localization | Nucleus . Cytoplasm. Present in the nucleus and cytoplasm, but shows increased nuclear translocation after activation of T-cells.. | |
Protein Description | AP-1 family transcription factor that controls the differentiation of lineage-specific cells in the immune system: specifically mediates the differentiation of T-helper 17 cells (Th17), follicular T-helper cells (TfH), CD8(+) dendritic cells and class-switch recombination (CSR) in B-cells. Acts via the formation of a heterodimer with JUNB that recognizes and binds DNA sequence 5'-TGA[CG]TCA-3'. The BATF-JUNB heterodimer also forms a complex with IRF4 (or IRF8) in immune cells, leading to recognition of AICE sequence (5'-TGAnTCA/GAAA-3'), an immune-specific regulatory element, followed by cooperative binding of BATF and IRF4 (or IRF8) and activation of genes. Controls differentiation of T-helper cells producing interleukin-17 (Th17 cells) by binding to Th17-associated gene promoters: regulates expression of the transcription factor RORC itself and RORC target genes such as IL17 (IL17A or IL17B). Also involved in differentiation of follicular T-helper cells (TfH) by directing expression of BCL6 and MAF. In B-cells, involved in class-switch recombination (CSR) by controlling the expression of both AICDA and of germline transcripts of the intervening heavy-chain region and constant heavy-chain region (I(H)-C(H)). Following infection, can participate in CD8(+) dendritic cell differentiation via interaction with IRF4 and IRF8 to mediate cooperative gene activation. Regulates effector CD8(+) T-cell differentiation by regulating expression of SIRT1. Following DNA damage, part of a differentiation checkpoint that limits self-renewal of hematopoietic stem cells (HSCs): up-regulated by STAT3, leading to differentiation of HSCs, thereby restricting self-renewal of HSCs (By similarity).. | |
Protein Sequence | MPHSSDSSDSSFSRSPPPGKQDSSDDVRRVQRREKNRIAAQKSRQRQTQKADTLHLESEDLEKQNAALRKEIKQLTEELKYFTSVLNSHEPLCSVLAASTPSPPEVVYSAHAFHQPHVSSPRFQP | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
35 | Acetylation | RRVQRREKNRIAAQK HHHHHHHHHHHHHHH | 50.11 | 25825284 | |
43 | Phosphorylation | NRIAAQKSRQRQTQK HHHHHHHHHHHHHHH | 22.89 | 12809553 | |
48 | Phosphorylation | QKSRQRQTQKADTLH HHHHHHHHHHHHHCC | 33.94 | 12809553 | |
76 | Phosphorylation | RKEIKQLTEELKYFT HHHHHHHHHHHHHHH | 25.56 | - | |
99 | Phosphorylation | LCSVLAASTPSPPEV CHHHHHHCCCCCCCC | 34.93 | 28348404 | |
100 | Phosphorylation | CSVLAASTPSPPEVV HHHHHHCCCCCCCCE | 24.06 | 28348404 | |
102 | Phosphorylation | VLAASTPSPPEVVYS HHHHCCCCCCCCEEE | 53.85 | 28348404 | |
108 | Phosphorylation | PSPPEVVYSAHAFHQ CCCCCCEEECCCCCC | 12.81 | 28348404 | |
109 | Phosphorylation | SPPEVVYSAHAFHQP CCCCCEEECCCCCCC | 11.28 | 28348404 | |
119 | Phosphorylation | AFHQPHVSSPRFQP- CCCCCCCCCCCCCC- | 31.43 | 28348404 | |
120 | Phosphorylation | FHQPHVSSPRFQP-- CCCCCCCCCCCCC-- | 21.00 | 28348404 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of BATF_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference |
---|---|---|---|---|
43 | S | Phosphorylation |
| - |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of BATF_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
IN35_HUMAN | IFI35 | physical | 8954125 | |
BATF3_HUMAN | BATF3 | physical | 23661758 | |
BATF_HUMAN | BATF | physical | 23661758 | |
ATF3_HUMAN | ATF3 | physical | 23661758 | |
ATF4_HUMAN | ATF4 | physical | 23661758 | |
JUNB_HUMAN | JUNB | physical | 23661758 | |
DBP_HUMAN | DBP | physical | 23661758 | |
ATF2_HUMAN | ATF2 | physical | 23661758 | |
CEBPE_HUMAN | CEBPE | physical | 23661758 | |
CEBPA_HUMAN | CEBPA | physical | 23661758 | |
CEBPG_HUMAN | CEBPG | physical | 23661758 | |
DDIT3_HUMAN | DDIT3 | physical | 23661758 | |
KDM1A_HUMAN | KDM1A | physical | 23455924 | |
GOPC_HUMAN | GOPC | physical | 25416956 | |
JUNB_HUMAN | JUNB | physical | 21516116 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...